Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: Results from the Italian Psocare Registry
(370)
Piaserico, Stefano
a
Cazzaniga, Simone
b
Chimenti, S
dn
Giannetti, A
cl
MacCarone, Mara
e
Picardo, Mauro
f
Peserico, A
a
Naldi, Luigi
b
Griseta, V
g
Miracapillo, A
g
Azzini, M
h
Mocci, L
h
Michelini, M
h
Offidani, A
i
Bernardini, L
i
Campanati, A
i
Ricotti, G
j
Giacchetti, A
j
Norat, M
k
Gualco, F
k
Castelli, A
l
Cuccia, A
l
Diana, A
l
Roncarolo, G
m
Belli, M A
n
Baldassarre, M A
n
Santoro, G
o
Vena, G A
p
Lo Console, F
p
Filotico, R
p
Mastrandrea, V
p
Brunetti, B
q
Musumeci, F
q
Carrabba, E
r
Dal Mas, P
r
Annicchiarico, F
r
Benvegnu B
r
Spaziani, G
r
Cusano, F
s
Saletta Iannazzone, S
s
Galluccio, A
t
Pezza, M
t
Marchesi, L
u
Imberti, G
u
Reseghetti, A
u
Barbera, C
v
Reggiani, M
w
Lanzoni, A
w
Patrizi, A
x
Bardazzi, F
x
Antonucci, A
x
De Tommaso, S
x
Balestri, R
x
Wallnofer, W
y
Ingannamorte, F
y
Calzavara Pinton, P
z
Iannazzi, S
z
Zane, C
z
Capezzera, R
z
Bassisi, S
z
Rossi, M T
z
Altamura, V
aa
Vigl, W
ab
Nobile, C
ab
Aste, N
ac
Murgia, S
ac
Mugheddu, C
ac
Scuderi, G
ad
Baglieri, F
ad
Di Dio, C
ad
Cilioni Grilli, E
ae
Mastronardi, C
af
Agnusdei, C P
af
Antrilli, A
af
Aulisa, L
ag
Raimondo, U
ah
Scotto di Luzio, G
ah
Battarra, V C
ah
Farro, P
ah
Plaitano, R
ah
Micali, G
ai
Musumeci, M L
ai
Massimino, D
ai
Li Calzi, M
ai
La Greca, S
aj
Pettinato, M
ak
Sapienza, G
ak
Valenti, G
al
De Giacomo, P F
al
d'Amico D
al
Arcangeli, F
am
Brunelli, D
am
Ghetti, E
am
Tulli, A
an
Assi, G
an
Amerio, P
an,dm
Laria, G
ao
Prestinari, F
ao
Spadafora, S
ap
Coppola, M
ap
Caresana, G
aq
Pezzarossa, E
aq
Domaneschi, E
aq
Felisi, C
aq
Donato, L
ar
Bertero, M
as
Musso, L
as
Pa lazzini, S
as
Bruscino, P
at
Agozzino, U C
au
Ottaviani, M
av
Simoncini, C
av
Virgili, A
aw
Osti, F
aw
Fabbri, P
ax
Volpi, W
ax
Caproni, M
ax
Lotti, T
ay
Prignano, F
ay
Buggiani, G
ay
Troiano, M
ay
Fenizi, G
az
Altobella, A
az
Amoruso, A
az
Condello, M
az
Goffredo, A
az
Righini, M G
ba
Alessandrini, F
ba
Satolli, F
ba
Zampetti, M
bb
Bertani, E
bc
Fossati, S
bc
Parodi, A
bd
Burlando, M
bd
Fiorucci, C
bd
Nigro, A
be
Ghigliotti, G
be
Massone, L
bf
Moise, G M
bg
Serrai, M
bh
Cannata, G
bi
Campagnoli, A M
bi
Daly, M
bj
Leporati, C
bj
Peila, R
bj
Filosa, G
bk
Bugatti, L
bk
Nicolini, M
bk
Nazzari, G
bl
Cestari, R
bl
Anastasio, F
bm
Larussa, F M
bm
Pollice, N
bn
De Francesco, F
bn
Mazzocchetti, G
bn
Peris, K
bo
Fargnoli, M C
bo
Di Cesare, A
bo
De Angelis, L
bo
Flati, G
bp
Biamonte, A S
bp
Quarta, G
bq
Congedo, M
bq
Carcaterra, A
br
Strippoli, D
br
Fideli, D
br
Marsili, F
bs
Celli, M
bs
Ceccarini, M
bt
Bachini, L
bt
D'Oria M
bt
Schirripa, V
bu
De Filippi, C
bv
Martini, P
bw
Lapucci, E
bw
Mazzatenta, C
bw
Ghilardi, A
bw
Simonacci, M
bx
Bettacchi, A
bx
Gasco, R
bx
Zanca, A
by
Battistini, S
bz
Dattola, S
ca
Vernaci, R
ca
Postorino, F
ca
Zampieri, P F
cb
Padovan, C
cb
Gonzalez Intchaurraga M A
cb
Ladurner, J
cb
Guarneri, B
cc
Cannavo S P
cc
Manfre C
cc
Borgia, F
cc
Puglisi Guerra, A
cd
Sedona, P
ce,ep
Cattaneo, A
cf
Carrera, C
cf
Fracchiolla, C
cf
Mozzanica, N
cf
Prezzemolo, L
cf
Menni, S
cg
Lodi, A
cg
Martino, P
cg
Monti, M
ch
Mancini, L
ch
Sacrini, F
ch
Altomare, G F
ci
Taglioni, M
ci
Lovati, C
ci
Mercuri, S R
cj
Schiesari, G
ck
Conti, A
cl
Lasagni, C
cl
Greco, M
cl
Ronsini, G
cl
Schianchi, S
cl
Fiorentini, C
cl
Niglietta, S
cl
Maglietta, R
cl
Padalino, C
cl
Crippa, D
cm
Pini, M
cm
Rossi, E
cm
Tosi, D
cm
Armas, M
cm
Ruocco, V
cn
Ayala, F
co
Balato, N
co
Gaudiello, F
co
Cimmino, G F
co
Monfrecola, G
co
Gallo, L
co
Argenziano, G
cp
Fulgione, E
cp
Berruti, G
cq
Ceparano, S
cr
De Michele, I
cr
Giorgiano, D
cs
Leigheb, G
ct
Deledda, S
cu
Alaibac, M
a
Schiesari, L
a
Dan, G
a
Mattei, I
a
Oro, E
a
Arico M
cv
Bongiorno, M R
cv
Angileri, R
cv
Amato, S
cw
Todaro, F
cw
Milioto, M
cw
Bellastro, R
cw
Di Nuzzo, S
cx
De Panfilis, G
cx
Zanni, M
cx
Borroni, G
cy
Cananzi, R
cy
Brazzelli, V
cy
Lisi, P
cz
Stingeni, L
cz
Hansel, K
cz
Pierfelice, V
da
Donelli, S
db
Rastelli, D
db
Gasperini, M
db
Barachini, P
dc
Cecchi, R
dd
Bartoli, L
dd
Pavesi, M
dd
De Paola, S
de
Corradin, M T
df
Ricciuti, F
dg
Piccirillo, A
dg
Viola, L
dg
Tataranni, M
dg
Mautone, M G
dg
Lo Scocco, G
dh
Niccoli, M C
dh
Brunasso Vernetti, A M G
dh
Gaddoni, G
di
Resta, F
di
Casadio, M C
di
Arcidiaco, M C
dj
Luvara M C
dj
Albertini, G
dk
Di Lernia, V
dk
Guareschi, E
dk
Catrani, S
dl
Morri, M
dl
De Simone, C
dm
D'Agostino M
dm
Agostino, I
dm
Calvieri, S
dn
Cantoresi, F
dn
Richetta, A
dn
Sorgi, P
dn
Carnevale, C
dn
Nicolucci, F
dn
Berardesca, E
f
Ardigo M
f
De Felice, C
f
Gubinelli, E
do
Talamonti, M
dn
Camplone, G
dp
Cruciani, G
dq
Riccardi, F
dq
Barbati, R
dr
Zumiani, G
ds,ej
Pagani, W
dt
Malagoli, P G
l
Pellicano, R
du
Donadio, D
dv
Di Vito, C
dv
Cottoni, F
dw
Montesu, M A
dw
Pirodda, C
dw
Addis, G
dw
Marongiu, P
dw
Farris, A
dx
Cacciapuoti, M
dx
Verrini, A
dx
Desirello, G
dy
Gnone, M
dy
Fimiani, M
dz
Pellegrino, M
dz
Castelli, G
ea
Zappala L
ea
Sesana, G
eb
Ingordo, V
ec
Vozza, E
ed
Di Giuseppe, D
ed
Fasciocco, D
ee
Nespoli, P
ee
Papini, M
ef
Cicoletti, M
ef
Bernengo, M G
eg
Ortoncelli, M
eg
Bonvicino, A
eg
Capella, G
eg
Doveil, G C
eg
Forte, M
eg
Peroni, A
eg
Salomone, B
eg
Savoia, P
eg
Pippione, M
eh
Zichichi, L
ei
Frazzitta, M
ei
De Luca, G
ei
Tasin, L
ej
Simonetto, D
ek
Ros, S
ek
Trevisan, G
el
Patamia, M
el
Miertusova, S
el
Patrone, P
em
Frattasio, A
em
Piccirillo, F
em
La Spina, S
em
Di Gaetano, L
em
Marzocchi, V
en
Motolese, A
eo
Venturi, C
eo
Gai, F
ep
Pasquinucci, S
ep
Bellazzi, R M
eq
Silvestri, T
eq
Girolomoni, G
er
Gisondi, P
er
Veller Fornasa, C
es
Trevisan, G P
es
more..
|
-
1
-
-
47549107863
-
Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: A meta-analysis of randomized controlled trials
-
A.K. Brimhall, L.N. King, J.C. Licciardone, H. Jacobe, and A. Menter Safety and efficacy of alefacept, efalizumab, etanercept and infliximab in treating moderate to severe plaque psoriasis: a meta-analysis of randomized controlled trials Br J Dermatol 159 2008 274 285
-
(2008)
Br J Dermatol
, vol.159
, pp. 274-285
-
-
Brimhall, A.K.1
King, L.N.2
Licciardone, J.C.3
Jacobe, H.4
Menter, A.5
-
2
-
-
84873427294
-
Sequential use of biologics in the treatment of moderate-to-severe plaque psoriasis
-
J. Leman, and A.D. Burden Sequential use of biologics in the treatment of moderate-to-severe plaque psoriasis Br J Dermatol 167 Suppl 2012 12 20
-
(2012)
Br J Dermatol
, vol.167
, pp. 12-20
-
-
Leman, J.1
Burden, A.D.2
-
3
-
-
84872852757
-
Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: Evidence from the Italian Psocare registry
-
Psocare Study Group
-
P. Gisondi, S. Cazzaniga, S. Chimenti, A. Giannetti, M. Maccarone, M. Picardo Psocare Study Group Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare registry J Eur Acad Dermatol Venereol 27 2013 e30 e41
-
(2013)
J Eur Acad Dermatol Venereol
, vol.27
-
-
Gisondi, P.1
Cazzaniga, S.2
Chimenti, S.3
Giannetti, A.4
MacCarone, M.5
Picardo, M.6
-
4
-
-
84866401186
-
The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: Results of a prospective, multicenter, open-label study
-
A.B. Gottlieb, R.E. Kalb, A. Blauvelt, M.P. Heffernan, H.L. Sofen, and L.K. Ferris et al. The efficacy and safety of infliximab in patients with plaque psoriasis who had an inadequate response to etanercept: results of a prospective, multicenter, open-label study J Am Acad Dermatol 67 2012 642 650
-
(2012)
J Am Acad Dermatol
, vol.67
, pp. 642-650
-
-
Gottlieb, A.B.1
Kalb, R.E.2
Blauvelt, A.3
Heffernan, M.P.4
Sofen, H.L.5
Ferris, L.K.6
-
5
-
-
34447293977
-
Adalimumab for severe psoriasis and psoriatic arthritis: An open-label study in 30 patients previously treated with other biologics
-
M. Papoutsaki, M.S. Chimenti, A. Costanzo, M. Talamonti, A. Zangrilli, and A. Giunta et al. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics J Am Acad Dermatol 57 2007 269 275
-
(2007)
J Am Acad Dermatol
, vol.57
, pp. 269-275
-
-
Papoutsaki, M.1
Chimenti, M.S.2
Costanzo, A.3
Talamonti, M.4
Zangrilli, A.5
Giunta, A.6
-
6
-
-
70349323598
-
Experience with biologics for psoriasis in daily practice: Switching is worth a try
-
L.L. Lecluse, M. de Groot, J.D. Bos, and P.I. Spuls Experience with biologics for psoriasis in daily practice: switching is worth a try Br J Dermatol 161 2009 948 951
-
(2009)
Br J Dermatol
, vol.161
, pp. 948-951
-
-
Lecluse, L.L.1
De Groot, M.2
Bos, J.D.3
Spuls, P.I.4
-
7
-
-
68949148678
-
Efficacy and safety of etanercept in psoriasis after switching from other treatments: An observational study
-
A. Mazzotta, M. Esposito, A. Costanzo, and S. Chimenti Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study Am J Clin Dermatol 10 2009 319 324
-
(2009)
Am J Clin Dermatol
, vol.10
, pp. 319-324
-
-
Mazzotta, A.1
Esposito, M.2
Costanzo, A.3
Chimenti, S.4
-
8
-
-
79952812411
-
Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study
-
B.E. Strober, Y. Poulin, F.A. Kerdel, R.G. Langley, Y. Gu, and S.R. Gupta et al. Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: efficacy and safety results from an open-label study J Am Acad Dermatol 64 2011 671 681
-
(2011)
J Am Acad Dermatol
, vol.64
, pp. 671-681
-
-
Strober, B.E.1
Poulin, Y.2
Kerdel, F.A.3
Langley, R.G.4
Gu, Y.5
Gupta, S.R.6
-
9
-
-
43049086693
-
Efficacy of etanercept in psoriatic patients previously treated with infliximab
-
G. Pitarch, J.L. Sánchez-Carazo, L. Mahiques, and V. Oliver Efficacy of etanercept in psoriatic patients previously treated with infliximab Dermatology 216 2008 312 316
-
(2008)
Dermatology
, vol.216
, pp. 312-316
-
-
Pitarch, G.1
Sánchez-Carazo, J.L.2
Mahiques, L.3
Oliver, V.4
-
10
-
-
80052883932
-
An open-label, prospective cohort pilot study to evaluate the efficacy and safety of etanercept in the treatment of moderate to severe plaque psoriasis in patients who have not had an adequate response to adalimumab
-
R. Vender An open-label, prospective cohort pilot study to evaluate the efficacy and safety of etanercept in the treatment of moderate to severe plaque psoriasis in patients who have not had an adequate response to adalimumab J Drugs Dermatol 10 2011 396 402
-
(2011)
J Drugs Dermatol
, vol.10
, pp. 396-402
-
-
Vender, R.1
-
11
-
-
80051692385
-
Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumor necrosis factor agents: Subanalysis of BELIEVE
-
J.P. Ortonne, S. Chimenti, K. Reich, R. Gniadecki, P. Sprøgel, and K. Unnebrink et al. Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumor necrosis factor agents: subanalysis of BELIEVE J Eur Acad Dermatol Venereol 25 2011 1012 1020
-
(2011)
J Eur Acad Dermatol Venereol
, vol.25
, pp. 1012-1020
-
-
Ortonne, J.P.1
Chimenti, S.2
Reich, K.3
Gniadecki, R.4
Sprøgel, P.5
Unnebrink, K.6
-
12
-
-
77957021921
-
Switching to adalimumab in patients with moderate to severe psoriasis who have failed on etanercept: A retrospective case cohort study
-
R.T. Woolf, C.H. Smith, K. Robertson, and J.N. Barker Switching to adalimumab in patients with moderate to severe psoriasis who have failed on etanercept: a retrospective case cohort study Br J Dermatol 163 2010 889 892
-
(2010)
Br J Dermatol
, vol.163
, pp. 889-892
-
-
Woolf, R.T.1
Smith, C.H.2
Robertson, K.3
Barker, J.N.4
-
13
-
-
77957021919
-
Switching from etanercept to adalimumab is effective and safe: Results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept
-
P.P. Van Lümig, L.L. Lecluse, R.J. Driessen, P.I. Spuls, J.B. Boezeman, and P.C. van de Kerkhof et al. Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept Br J Dermatol 163 2010 838 846
-
(2010)
Br J Dermatol
, vol.163
, pp. 838-846
-
-
Van Lümig, P.P.1
Lecluse, L.L.2
Driessen, R.J.3
Spuls, P.I.4
Boezeman, J.B.5
Van De Kerkhof, P.C.6
-
15
-
-
76749092658
-
Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis
-
L.L. Lecluse, R.J. Driessen, P.I. Spuls, E.M. de Jong, S.O. Stapel, and M.B. van Doorn et al. Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis Arch Dermatol 146 2010 127 132
-
(2010)
Arch Dermatol
, vol.146
, pp. 127-132
-
-
Lecluse, L.L.1
Driessen, R.J.2
Spuls, P.I.3
De Jong, E.M.4
Stapel, S.O.5
Van Doorn, M.B.6
-
16
-
-
70449725246
-
Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis
-
T.R. Radstake, M. Svenson, A.M. Eijsbouts, F.H. van den Hoogen, C. Enevold, and P.L. van Riel et al. Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis Ann Rheum Dis 68 2009 1739 1745
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 1739-1745
-
-
Radstake, T.R.1
Svenson, M.2
Eijsbouts, A.M.3
Van Den Hoogen, F.H.4
Enevold, C.5
Van Riel, P.L.6
-
17
-
-
34447319146
-
Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice
-
Research in Active Rheumatoid Arthritis (ReAct) Study Group
-
S. Bombardieri, A.A. Ruiz, P. Fardellone, P. Geusens, F. McKenna, K. Unnebrink Research in Active Rheumatoid Arthritis (ReAct) Study Group Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice Rheumatology 46 2007 1191 1199
-
(2007)
Rheumatology
, vol.46
, pp. 1191-1199
-
-
Bombardieri, S.1
Ruiz, A.A.2
Fardellone, P.3
Geusens, P.4
McKenna, F.5
Unnebrink, K.6
-
18
-
-
24944490986
-
Adalimumab in clinical practice: Outcome in 70 rheumatoid arthritis patients, including comparison of patients with and without previous anti-TNF exposure
-
A.N. Bennett, P. Peterson, A. Zain, J. Grumley, G. Panayi, and B. Kirkham Adalimumab in clinical practice: outcome in 70 rheumatoid arthritis patients, including comparison of patients with and without previous anti-TNF exposure Rheumatology 44 2005 1026 1031
-
(2005)
Rheumatology
, vol.44
, pp. 1026-1031
-
-
Bennett, A.N.1
Peterson, P.2
Zain, A.3
Grumley, J.4
Panayi, G.5
Kirkham, B.6
-
19
-
-
43049162899
-
Treatment response to a second or third TNF-inhibitor in RA: Results from the south Swedish arthritis treatment group register
-
J.A. Karlsson, L.E. Kristensen, M.C. Kapetanovic, A. Guülfe, T. Saxne, and P. Geborek Treatment response to a second or third TNF-inhibitor in RA: results from the south Swedish arthritis treatment group register Rheumatology 47 2008 507 513
-
(2008)
Rheumatology
, vol.47
, pp. 507-513
-
-
Karlsson, J.A.1
Kristensen, L.E.2
Kapetanovic, M.C.3
Guülfe, A.4
Saxne, T.5
Geborek, P.6
-
20
-
-
77953505954
-
Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy
-
M. Rudwaleit, F. Van den Bosch, M. Kron, S. Kary, and H. Kupper Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy Arthritis Res Ther 12 2010 R117
-
(2010)
Arthritis Res Ther
, vol.12
, pp. 117
-
-
Rudwaleit, M.1
Van Den Bosch, F.2
Kron, M.3
Kary, S.4
Kupper, H.5
|